gvtcx

Under-18 SARS-CoV-2 Vaccine Supply (2026)

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,000,000,000
Statuscomplete
Category (CPV) 33651600
RegionSouth East, London
Deadline23 Sept 2028
Procedureselective
OCIDocds-h6vhtk-048b76

Awards (3)

This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £1,000,000,000.

SupplierValueDateStatus
ACCORD-UK LTD shared · · active
Aventis Pharma Limited T/a Sanofi shared · · active
PFIZER LIMITED shared · · active

description

Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in Under-18s (2026).

notice history

5 notices published against this procurement.

PublishedTypeRegimeNotice
16 Aug 2024 Contract notice (F02) Earlier regulations 026083-2024
15 Jul 2025 Contract award notice (F03) Earlier regulations 039968-2025
17 Dec 2025 Contract award notice (F03) Earlier regulations 083659-2025
25 Jun 2026 Contract award notice (F03) Earlier regulations 059934-2026
2 Jul 2026 Contract award notice (F03) Earlier regulations 062139-2026

more from Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.